Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innocube is a healthcare-specialized accelerator and venture capital firm established by Hanmi Science, the holding company of South Korea's Hanmi Pharmaceutical Group. Founded in 2020, the company focuses on identifying and nurturing early-stage startups in the biotechnology, digital healthcare, and medical device sectors. Innocube provides its portfolio companies with seed funding, strategic consulting, and access to Hanmi's extensive R&D infrastructure and global network. By bridging the gap between innovative research and commercialization, Innocube aims to foster a robust healthcare ecosystem and drive the development of next-generation therapeutic and diagnostic solutions. The firm operates as a "company builder," offering hands-on operational support to ensure the success of its incubated ventures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innocube.